What is it?What's new?CompareEVMPD / IDMPTechnical Specifications
What's new?

Volume Create NEW

The Volume Create feature was implemented to enable batch creation of new objects and reduces time when creating similar items.

This feature also allows the batch creation of multiple items by using an existing item as a template.

During the creation process you can also define what should not be shared between the multiple records (e.g. when creating Marketing Authorizations for different countries).

Configure Default Starting Page NEW

The starting page for drugTrack can now be configured and it is possible to choose the preferred option: The Dashboard with customized reports provides an overview entry while the classical Explorer like page is designed for fast access to specific Business Objects.

Business Object Changes NEW

In the next step towards IDMP, a new and IDMP compliant data model has been implemented into drugTrack and the Composition, Packaging and Marketing Authorization objects have been reworked. The new structure allows customers to start preparing their IDMP data.

Composition: The Composition object can be defined as being identical to a pharmaceutical product (PHP) or not. In the second case the composition does not enter the patient‘s body without reconstitution and a separate PHP is required.

Packaging: The definition was enhanced to enable maintenance and data entry in higher details (e.g. a blister including several different compositions or combination products such as a product consisting of a box, which includes blisters with compositions, a cream in a tube and an application device). In an overview called package info, users are provided with a summary of all included compositions.

Marketing Authorization: According to IDMP, the MA-Object now allows for the differentiation of manufactured item and pharmaceutical products. In addition, each package used in the MA-object can have its own MA-Status and approval dates.

Multi-Selection of Records NEW

In order to simplify the selection and multi-selection of records in the Results Pane and Book Button, check-boxes were added. Simply use the checkboxes to select the desired objects by either clicking on them individually or using shift+click to multiselect them. Then use the context or Actions menu to initiate the desired action.

Other Highlights

Enhanced Grid Searches in the Browser Client

It is now possible to search for underlying objects immediately from the higher level object. Within marketing authorizations, you are now able to search for and filter by substances or other criteria.

Editing EVMPD Data in a Browser Client

The browser client is now capable of editing and validating all information in a marketing authorization. This enables the managing of all EVMPD-relevant changes in the new web client.

Receiving the EMA 3rd ACK Messages with the Desktop Client

The desktop client has been enhanced in order to receive 3rd ACK messages coming from the EMA, as a quality review of EVMPD messages. The scheduler service has also been extended to support this task.

Prepare to be Stunned: A Brand-New Web User Interface!

LORENZ drugTrack 5 now boasts a brand-new web user view client. Based on feedback from user interviews, the new client was consciously designed to provide an enhanced user experience. When working with the new client, you will notice that Navigation within your Product and Regulatory Information is greatly improved. With drugTrack 5 you can find the required data directly and can seamlessly navigate through your data. If you didn´t know, you wouldn´t think it was a web interface!

Create "Ad-hoc" Reports

drugTrack provides advanced filter functionality. With this feature you can find answers to questions directly in the tool, create a print friendly view or export it to Microsoft Excel for further processing

Structured Detail Information

drugTrack now provides a new configurable layout that allows you to display detailed product information in a structured format. The new Details Scroll-bar allows you to jump directly to the area of interest and new Tabs provide additional layout options. In addition, companies can configure a Summary Page which includes all information relevant to their work-environments.

Controlled Vocabulary Updates

When complying to external standards that you do not control, such as the xEVMPD standard, you are faced with continuously changing vocabulary lists. With drugTrack, you can now automatically update these vocabulary lists. drugTrack will guide you through the entire update process, let you know which records may be affected (if any), and help you make alternative choices. There is no longer a need to be worried about changes you cannot control.

Improved Workflow through Related Submissions

Some registrations are connected. For example, if you use Mutual Recognition procedures to register your product then you can now create a group of selected registrations and share data between them.

Easy Data Comparison

You can now highlight all changes made within one marketing authorisation very quick and easy. Time consuming comparisons between the older and the newer version of one marketing authorisation is no longer needed. The marked entries tell you what has changed between the versions.

Email Notifications

You want to have e-mail notifications of all the due dates from your regulatory lifecycle? You do not want to open the program every morning to see what tasks you have for today? With the new version of drugTrack you will receive an e-mail notifications for all marketing authorisations that need to be renewed, PSUR that have to be filed and all other actions with other due dates you have entered. So you will never forget what to do next to fulfil all your deadlines.


An audit trail is available with the new version of drugTrack. Administrators can easily view and report on any changes within the user interface.


drugTrack now offers a dashboard with pre-configured filters which provide exportable information.

Clicking on a chart will open a Details Pane that displays the relevant information.